Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank9
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-348.88M
↓ 84% vs avg
Percentile
P9
Near historical low
Average
$-189.37M
Historical baseline
PeriodValueYoY Change
2025$-348.88M0.0%
2024$-348.88M+11.5%
2023$-394.09M-18.2%
2022$-333.29M-48.1%
2021$-225.03M-350.9%
2020$-49.91M+51.7%
2019$-103.24M-68.5%
2018$-61.26M+6.2%
2017$-65.28M-280.8%
2016$36.11M-